The pan-Canadian Pharmaceutical Alliance is a nonprofit organization that negotiates drug prices to enhance access to effective and affordable medications for Canadians.
The pan-Canadian Pharmaceutical Alliance (pCPA) is an independent, not-for-profit organization whose membership includes the provincial, territorial and federal governments. We negotiate drug costs with pharmaceutical companies for publicly funded drug programs, and through our combined negotiating power, increase and manage access to clinically effective and affordable drug treatments. Our objectives are to: • Increase access to relevant and cost-effective treatments • Achieve consistent and lower drug costs • Reduce duplication and optimize resource utilization • Improve consistency in funding decisions L’Alliance pharmaceutique pancanadienne (APP) est une organisation autonome à but non lucratif qui compte parmi ses membres les administrations gouvernementales provinciales, territoriales et fédérale. L’APP s’occupe de négocier le prix de médicaments auprès des compagnies pharmaceutiques au nom des régimes publics d’assurance médicaments et, grâce au pouvoir de négociation combiné de ses membres, elle réussit à élargir et à gérer l’accès à des médicaments cliniquement efficaces et abordables. L’APP a comme objectifs de : • élargir l’accès à des traitements cliniquement pertinents et rentables; • proposer des médicaments à prix stables et à moindres coûts; • réduire le double emploi et faire une utilisation optimale des ressources; • améliorer la cohérence des décisions en matière de financement.
Remote · Canada
The Senior Economist provides leadership and analytical expertise to support the pan-Canadian Pharmaceutical Alliance in drug negotiation strategies and financial evaluations. They lead complex projects, synthesize research findings, and coordinate with federal, provincial, and territorial partners to ensure evidence-based decision-making.
Remote · Canada
The Senior Economist provides leadership and expertise in health economic evaluations and financial analyses to support pan-Canadian pharmaceutical negotiations. This role involves developing negotiation strategies, conducting complex market assessments, and collaborating with federal, provincial, and territorial partners to achieve value-based outcomes.
